Sign in

CIK 0001566044

  • Non-accelerated filer
  • Smaller reporting company

Yarrow Bioscience, Inc.

Sign in to watch
Ticker
YARW
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
453757789
Phone
+1 203-433-7577
Business address
470 JAMES STREET, SUITE 007, NEW HAVEN, CT, 06513
Former names
VYNE Therapeutics Inc., Menlo Therapeutics Inc., Menlo Therapeutics, Inc., Tigercat Pharma, Inc.
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$0
in 0 filings

Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Reading 2 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2021-07-19 Bright Rex Director Grant or award · Stock Options +20,500 20,500
2021-07-19 Basta Steven L Director Grant or award · Stock Options +20,500 20,500
2021-07-19 BARBARI SHARON Director Grant or award · Stock Options +20,500 20,500
2021-06-30 Zeronda Tyler Interim CFO Shares withheld for taxes −700 $3.51 $2K 22,695
2021-06-30 Wiley Matthew T. Chief Commercial Officer Shares withheld for taxes −5,151 $3.51 $18K 109,246
2021-06-30 Stuart Iain Chief Scientific Officer Shares withheld for taxes −3,083 $3.51 $11K 95,750
2021-06-30 Harsch Mutya Chief Legal Officer and GC Shares withheld for taxes −3,551 $3.51 $12K 105,322
2021-06-30 Domzalski David President and CEO Shares withheld for taxes −18,859 $3.51 $66K 455,599
2021-05-28 Saik Andrew Chief Financial Officer Grant or award +3,017 $3.36 $10K 116,468
2021-05-28 Domzalski David President and CEO Grant or award +941 $3.36 $3K 474,458
2021-05-26 LEPORE PATRICK G Director Purchase +12,500 $3.60 $45K 37,500
2021-05-06 PERCEPTIVE ADVISORS LLC 10% owner Sale −1,000,000 $3.67 $3.7M 5,773,954
2021-03-31 Wiley Matthew T. Chief Commercial Officer Shares withheld for taxes −2,573 $6.84 $18K 114,397
2021-03-31 Stuart Iain Chief Scientific Officer Shares withheld for taxes −1,945 $6.84 $13K 98,833
2021-03-31 Saik Andrew Chief Financial Officer Shares withheld for taxes −762 $6.84 $5K 113,451
2021-03-31 Harsch Mutya Chief Legal Officer and GC Shares withheld for taxes −1,765 $6.84 $12K 108,873
2021-03-31 Domzalski David President and CEO Shares withheld for taxes −6,316 $6.84 $43K 473,517
2021-03-15 LEPORE PATRICK G Director Purchase +12,500 $7.41 $93K 25,000
2021-02-22 Wiley Matthew T. Chief Commercial Officer Grant or award +27,675 116,970
2021-02-22 Wiley Matthew T. Chief Commercial Officer Grant or award · Stock Options +64,575 64,575

Page 10 of 22 · 425 trades